Skip to content

FP7H2020HORIZON

Forschungszentrum Borstel Leibniz Lungenzentrum

Country
DEGermany
Defence projects
0
Projects, all programmes
19
As coordinator
3
EU contribution (CORDIS)
EUR 11,743,505
Active
2007 to 2025

Projects

19 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
STOOL4TBEvaluating a new stool based qPCR for diagnosis of tuberculosis in children and people living with HIVHORIZON2025ParticipantEUR 7,500
ERA4TBEUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSISH20202020ParticipantEUR 2,947,400
CORVOSCOmplement Regulation and Variations in Opportunistic infectionSH20202019ParticipantEUR 252,788
CARECOMMON ACTION AGAINST HIV/TB/HCV ACROSS THE REGIONS OF EUROPEH20202019ParticipantEUR 252,500
anTBioticAnTBiotic – progressing TB drug candidates to clinical proof of conceptH20202017ParticipantEUR 1,242,417
NAREBNanotherapeutics for antibiotic resistant emerging bacterial pathogensFP72014ParticipantEUR 363,466
ENABLEEuropean Gram Negative Antibacterial EngineFP72014ParticipantEUR 567,678
PATHONGEN-TRACENext Generation Genome Based High Resolution Tracing of PathogensFP72012CoordinatorEUR 1,058,280
EDENEXTBiology and control of vector-borne infections in EuropeFP72011ParticipantEUR 58,000
PIROVACImprovement of current and development of new vaccines for theileriosis and babesios of small ruminantsFP72010CoordinatorEUR 835,890
EUMEDNETVSTBBuilding a cooperative strategy between Europe and Mediterranean Countries for upgrading tuberculosis research and controlFP72010ParticipantEUR 42,800
THESCHISTOVACThe targeted development of a new generation Vaccine for SchistosomiasisFP72010ParticipantEUR 273,525
POSTICKPost-graduate training network for capacity building to control ticks and tick-borne diseasesFP72009ParticipantEUR 414,539
TB PAN-NETPan-European network for the study and clinical management of drug resistant tuberculosisFP72009ParticipantEUR 1,740,747
INFLA-CAREUnderstanding inflammation-associated tumorigenesis for the rational design of novel anti-cancer therapeutic strategiesFP72009ParticipantEUR 511,700
ARBO-ZOONETInternational network for capacity building for the control of emerging viral vector borne zoonotic diseasesFP72008ParticipantEUR 213,518
CUREHLHEuropean initiative to improve knowledge, treatment and survival of haemophagocytic syndromes in childrenFP72008ParticipantEUR 548,213
TM-RESTA new platform for fast molecular detection of MDR and XDR resistant strains of M. tuberculosis and of drug resistant malariaFP72008ParticipantEUR 312,543
MEMBRANE DYNAMICSThe role of membrane trafficking in immune cell functionFP72007CoordinatorEUR 100,000

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.